cyclic GMP PDE5 inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cyclic GMP PDE5 inhibitors, covering 2023-05-16 to 2023-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs [Phase 2]